Abstract:The mortality of livestock caused by pathogenic Escherichia coli (E. coli) still accounts for a large proportion of deaths in large-scale production and reproduction, which causes devastating economic losses to the pig breeding industry. The aims of this study were to investigate the antibacterial activity of combined aditoprim (ADP) and sulfamethoxazole (SMZ) against clinical isolates of E. coli from pigs and to develop a pharmacokinetic-pharmacodynamic (PK-PD) model to formulate the optimal dose of ADP/SMZ for the treatment of pig colibacillosis. Blood and ileum fluid samples were collected at different times after single intramuscular injection of ADP/SMZ (5/25 mg/kg b.w.) to healthy pigs and E. coli-infected pigs. Concentrations of ADP and SMZ in plasma and ileum fluid were analyzed by HPLC. The peak concentration (C-max) and the area under the concentration-time curve (AUC(0-24h)) in ileum fluid of healthy pigs were 1.76 +/- 0.27 mu g/ml and 18.92 +/- 2.87 mu g center dot h/ml for ADP and 19.15 +/- 2.63 mu g/ml and 125.70 +/- 11.86 mu g center dot h/ml for SMZ, respectively. C-max and AUC(0-24h) in ileum fluid of infected pigs were 1.88 +/- 0.13 mu g/ml and 15.12 +/- 0.75 mu g center dot h/ml for ADP and 19.71 +/- 3.68 mu g/ml and 133.92 +/- 17.14 mu g center dot h/ml for SMZ, respectively. The minimum inhibitory concentrations (MICs) of combined ADP and SMZ (ADP/SMZ) against 185 strains of E. coli from pigs were determined. The MIC50 and MIC90 of ADP/SMZ were 0.5/2.5 and 4/20 mu g/ml, respectively. The MIC of the selected pathogenic E. coli SHC28 was 0.5/2.5 mu g/ml in Mueller-Hinton broth and 0.25/1.25 mu g/ml in ileum fluid, respectively. In vitro, the mutant prevention concentration, the post-antibiotic effect, growth, and time-killing curves in vitro and ex vivo of ADP/SMZ against the isolate SHC28 were assayed for PD studies. The results showed that ADP/SMZ exhibited strong concentration-dependent antimicrobial activity against E. coli. After integrating the in vivo pharmacokinetic parameters of infected pigs and ex vivo PD data using the sigmoid E-max (Hill) equation, the AUC(24h)/MIC values in ileum fluid for bacteriostatic, bactericidal, and bacterial eradication were 18.84, 65.39, and 110.68 h, respectively. In conclusion, a dosage of 3.45/17.25 mg/kg ADP/SMZ by intramuscular injection daily for 3 consecutive days may be sufficient to treat swine colibacillosis due to E. coli with a MIC of 0.5/2.5 mu g/ml.

Determination of Mutant Prevention Concentrations of Three Antibacterial Agents Against Escherichia Coli from Piglet's Yellow-white Dysentery

Genotypic characterization and in vitro activities of tigecycline and polymyxin B for members of the Enterobacteriaceae with decreased susceptibility to carbapenems.

Surveillance of resistant pathogenic E.coli from post-weaning diarrhea on intensive pig farms in Zhejiang province

Drug Resistance to Four Antibiotics of Escherichia coli in Chicken and Pig Feces

Antibacterial Activity of Combined Aditoprim and Sulfamethoxazole Against Escherichia Coli from Swine and a Dose Regimen Based on Pharmacokinetic-Pharmacodynamic Modeling

Comparative Minimal Inhibitory and Mutant Prevention Concentration of Eight Antimicrobial Agents Against Klebsiella pneumoniae

Performance of Different Methods for Testing Polymyxin B: Comparison of Broth Microdilution, Agar Dilution and MIC Test Strip in Mcr-1 Positive and Negative Escherichia Coli

Investigation of Drug and Disinfectants Resistance of Pig Source E.coli O157 ∶ H7

Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus suis and Screen of Single-step Resistant Mutants

Antibiotic Sensitivity Detection and Analysis of Escherichia coli Isolated Clinically in China

Study of Drug Resistance and Plasmid Profiles of Escherichia Coli Leading to Piglet Diarrhea of Shaanxi Province

Quantitative proteomic analysis reveals the mechanisms of polymyxin B toxicity to <i>Escherichia coli</i>

Phenotypic and Aminoglycosides Genotypic Antimicrobial Resistance Characterization of Escherichia Coli Isolated from 95 Pig Farms

Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli

Quantitative proteomic analysis reveals the mechanisms of polymyxin B toxicity to Escherichia coli

Antimicrobial Sensitivity of Clinical Strains of Streptococcus Suis Isolated from Pigs and Human

Drug Sensitive Test of 84 E.coli Strains of yellow and white Sour of Piglet

Study on mutant selection window of Cefotaxime combination with Enrofloxacin against Escherichia coli isolated from cattle with F17 virulence genes

Antimicrobial resistance in Campylobacter coli isolated from pigs in two provinces of China

Isolation, Identification and Drug Resistance Analysis of Interstinal Pathogenic Escherichia coli and Salmonella Isolated from Diarrhea Piglets

Antimicrobial Resistance of Escherichia coli Isolated from Tibetan Piglets Suffering from White Score Diarrhea